Extracorporeal Shock Wave Treatment - Can the Pain be Reduced?

University of Zurich36 enrolled

Overview

Patients with Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii get the shock wave therapy in our clinic as planned. During our study the investigators want to ask for pain, pain reduction and function.

Patients with either Fascititis plantaris, Achillodynie, Periarthropathia humerosacpularis calcarea or Epikondylopathia humeri /radii get a shock wave therapy in our clinic of rheumatology as planned. During our study the investigators ask for pain, pain reduction and function (all questionnaires).

Study Type

OBSERVATIONAL

Enrollment

Conditions

Fasciitis, Plantar Achillodynia Periarthritis Calcarea Epikondylopathia Humeri /Radii

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion criteria: -Patients with: * Fascititis plantaris, * Achillodynie, * Periarthropathia humerosacpularis calcarea or * Epicondylopathia humeri /radii, who got the shock wave therapy. Exclusion criteria: * Anticoagulation, * Sepsis

Locations (1)

University Hospital

Zurich, Switzerland

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.